Moncef Mokni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Moncef Mokni has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Nabiha Missaoui
Research Laboratory LR21ES03, Oncogenesis and Tumor Progression, Medicine Faculty of Sousse, University of Sousse, Sousse, 4002, Tunisia
3 shared publications Sihem Hmissa
3 shared publications- Atef Ben Abdelkader
University of Sousse, Faculty of Medicine of Sousse, Department of Pathology, Farhat Hached University Hospital, Sousse, Tunisia
2 shared publications - Badra Bannour
University of Sousse, Faculty of Medicine of Sousse, Department of Obstetrics and Gynecology , Farhat Hached University Hospital of Sousse , Sousse , Tunisia
2 shared publications - Imen Bannour
Department of Obstetrics and Gynecology, University of Sousse, Faculty of Medicine of Sousse, Farhat Hached Teaching Hospital, Sousse, Tunisia
2 shared publications - Imen Chabchoub
Department of Medical Oncology, Farhat Hached Hospital, Sousse, Tunisia
2 shared publications
Latest Publications
- Open Access
- 21 November 2025
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 51 (3) , 394-404
Correlation of epigenetic markers with glioblastoma patients’ survival and molecular subtypes: insights from methylation-specific MLPA analysis
Objectives: Glioblastoma (GB) is a heterogeneous group of tumors with poor patient’s outcome. The epigenetic markers could influence patient’s outcome and add more precision in sub-typing. Methods: The study aims to determine a correlation between the methylation status of 65 genes and the overall survival (OS) in 50 GB Tunisian patients using methylation specific-multiplex ligation-dependent probe amplification (MS-MLPA) technique. Results: OS was significantly longer for patients with tumors harboring unmethylated tumor suppressor genes ATM , BRCA1 , BRCA2 , TP53 and TP73 and the DNA repairing gene MSH6 . Furthermore, simultaneous unmethylation of ATM , BRCA2 , CD44 and VHL genes was associated with GB presenting normal EGFR status. This subgroup exhibits a better prognosis (OS=15 months, p=0.005). Our results also showed that, combined methylation of TP73 , THBS1 , GSTP1 and ESR1 genes in amplified EGFR GB subtype resulted in a poor prognosis group (OS=3 months, p=0.041). Simultaneous methylation of HLTF and SFRP5 genes was associated with wild-type IDH1 GB defining therefore a very poor prognosis group (OS=1 month, p=0.026). Besides, BRCA1 methylation in wild-type IDH1 group was significantly associated with poor prognosis (OS=6 months, p=0.002). Interestingly, RBM14 and PCCA genes were co-methylated in 80 % of prolonged survival cases (GB+). In absence of EGFR amplification and with unmethylation of BRCA1 , BRCA2 , ATM , VHL , CD44 , HLTF and SFRP5 genes, GB+ tumors seemed to respond better to treatment, avoiding the relapse and conferring prolonged survival (>36 months). Conclusions: Combining genes methylation status of GB with EGFR and IDH1 profiles will refine subtyping, predict patient’s outcomes and guide personalized therapy.
- 21 November 2025
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 51 (3) , 394-404
Open AccessCorrelation of epigenetic markers with glioblastoma patients’ survival and molecular subtypes: insights from methylation-specific MLPA analysis
Objectives: Glioblastoma (GB) is a heterogeneous group of tumors with poor patient’s outcome. The epigenetic markers could influence patient’s outcome and add more precision in sub-typing. Methods: The study aims to determine a correlation between the methylation status of 65 genes and the overall survival (OS) in 50 GB Tunisian patients using methylation specific-multiplex ligation-dependent probe amplification (MS-MLPA) technique. Results: OS was significantly longer for patients with tumors harboring unmethylated tumor suppressor genes ATM , BRCA1 , BRCA2 , TP53 and TP73 and the DNA repairing gene MSH6 . Furthermore, simultaneous unmethylation of ATM , BRCA2 , CD44 and VHL genes was associated with GB presenting normal EGFR status. This subgroup exhibits a better prognosis (OS=15 months, p=0.005). Our results also showed that, combined methylation of TP73 , THBS1 , GSTP1 and ESR1 genes in amplified EGFR GB subtype resulted in a poor prognosis group (OS=3 months, p=0.041). Simultaneous methylation of HLTF and SFRP5 genes was associated with wild-type IDH1 GB defining therefore a very poor prognosis group (OS=1 month, p=0.026). Besides, BRCA1 methylation in wild-type IDH1 group was significantly associated with poor prognosis (OS=6 months, p=0.002). Interestingly, RBM14 and PCCA genes were co-methylated in 80 % of prolonged survival cases (GB+). In absence of EGFR amplification and with unmethylation of BRCA1 , BRCA2 , ATM , VHL , CD44 , HLTF and SFRP5 genes, GB+ tumors seemed to respond better to treatment, avoiding the relapse and conferring prolonged survival (>36 months). Conclusions: Combining genes methylation status of GB with EGFR and IDH1 profiles will refine subtyping, predict patient’s outcomes and guide personalized therapy.
- Open Access
- 11 March 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (2) , 182-185
Isolated Hydatid Cyst of the Breast: A Rare Pseudotumor of the Breast
Isolated Hydatid Cyst of the Breast: A Rare Pseudotumor of the Breast - European Journal of Breast Health
- 11 March 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (2) , 182-185
Open AccessIsolated Hydatid Cyst of the Breast: A Rare Pseudotumor of the Breast
Isolated Hydatid Cyst of the Breast: A Rare Pseudotumor of the Breast - European Journal of Breast Health
- Open Access
- 2 January 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (1) , 85-89
From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis
From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis - European Journal of Breast Health
- 2 January 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (1) , 85-89
Open AccessFrom Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis
From Plasmacytoma to Rib Tuberculosis: The Case of A Breast Mass With An Unexpected Diagnosis - European Journal of Breast Health
- 30 June 2022
- Published by JLE in Annales de biologie clinique
- Vol. 80 (3) , 233-243
Clinicopathological and prognostic significance of DNA mismatch-repair protein expression in gastric adenocarcinoma
Although the significance of DNA mismatch repair (MMR) protein expression in colorectal cancer is well-established, it remains contentious in extra-colorectal cancers and mainly in gastric adenocarcinoma. Data from Africa and Arab world remain limited. This study explored the MMR expression in gastric adenocarcinoma and evaluated its clinicopathological and prognostic signification among Tunisian patients. A retrospective study of 72 gastric adenocarcinomas was carried out. Clinicopathological particularities and patient outcomes were recorded. MMR expression was determined by immunohistochemistry on whole sections of archived material. Survival analysis was realized utilizing the Kaplan-Meier estimates and Log-Rank test. Expression of MMR proteins was observed in 84.7% of gastric adenocarcinoma samples. The 11 remaining samples (15.3%) exhibited an altered pattern of MMR protein. A significant association was identified between deficient MMR expression and advanced age (p = 0.03), intestinal type (p = 0.04) and lymph node metastases (p = 0.04). No other significant relationship was observed with the remaining selected tumor features. Patient survival was significantly associated with lymph node invasion (p = 0.002), distant metastases (p = 0.02) and tumor differentiation (p = 0.03), but not with MMR status (p = 0.83). MMR deficiency was related to advanced-age, intestinal type and nodal metastasis, but not to survival of Tunisian patients with gastric adenocarcinoma. Larger multicenter studies with additional molecular investigation are required to more explore these tumors.
- 30 June 2022
- Published by JLE in Annales de biologie clinique
- Vol. 80 (3) , 233-243
Clinicopathological and prognostic significance of DNA mismatch-repair protein expression in gastric adenocarcinoma
Although the significance of DNA mismatch repair (MMR) protein expression in colorectal cancer is well-established, it remains contentious in extra-colorectal cancers and mainly in gastric adenocarcinoma. Data from Africa and Arab world remain limited. This study explored the MMR expression in gastric adenocarcinoma and evaluated its clinicopathological and prognostic signification among Tunisian patients. A retrospective study of 72 gastric adenocarcinomas was carried out. Clinicopathological particularities and patient outcomes were recorded. MMR expression was determined by immunohistochemistry on whole sections of archived material. Survival analysis was realized utilizing the Kaplan-Meier estimates and Log-Rank test. Expression of MMR proteins was observed in 84.7% of gastric adenocarcinoma samples. The 11 remaining samples (15.3%) exhibited an altered pattern of MMR protein. A significant association was identified between deficient MMR expression and advanced age (p = 0.03), intestinal type (p = 0.04) and lymph node metastases (p = 0.04). No other significant relationship was observed with the remaining selected tumor features. Patient survival was significantly associated with lymph node invasion (p = 0.002), distant metastases (p = 0.02) and tumor differentiation (p = 0.03), but not with MMR status (p = 0.83). MMR deficiency was related to advanced-age, intestinal type and nodal metastasis, but not to survival of Tunisian patients with gastric adenocarcinoma. Larger multicenter studies with additional molecular investigation are required to more explore these tumors.
- Open Access
- 21 April 2020
- Published by Peertechz Publications Private Limited in Annals of Cytology and Pathology
- Vol. 5 (1) , 044-047
Mitotically active fibrothecoma in association with sclerous peritonitis
Mitotically active fibrothecoma associated with sclerosing peritonitis is an enigmatic and rare condition, described by Clement et al. in 1994, with fewer than 50 pathologically characterized cases. Association of these two lesions is extremely rare and the etiology currently remains unclear; therefore, association with anti-epileptic drugs was suggested.
- 21 April 2020
- Published by Peertechz Publications Private Limited in Annals of Cytology and Pathology
- Vol. 5 (1) , 044-047
Open AccessMitotically active fibrothecoma in association with sclerous peritonitis
Mitotically active fibrothecoma associated with sclerosing peritonitis is an enigmatic and rare condition, described by Clement et al. in 1994, with fewer than 50 pathologically characterized cases. Association of these two lesions is extremely rare and the etiology currently remains unclear; therefore, association with anti-epileptic drugs was suggested.
- Open Access
- 1 January 2015
- Published by Elmer Press, Inc. in World Journal of Nephrology and Urology
- Vol. 4 (3) , 242-246
Primary Seminal Vesicle Adenocarcinoma Presenting as Acute Urinary Retention and Hematuria: A Case Report
Primary tumors of the seminal vesicle are extremely rare lesions, and adenocarcinoma is the most common histology found. We report the case of a 54-year-old patient who has consulted with a bladder outlet obstruction and two episodes of initial hematuria for 3 months. Digital rectal examination revealed a hard, palpable mass in the prostate wall. The prostate-specific antigen (PSA), the serum carcinoembryonic antigen and the cancer antigen 125 (CA125) were normal. On imaging, a prostatic abscess, granulomatous prostatitis or a prostatic cancer were highly suspected at first. But the patient was afebrile and PSA was normal. Transrectal ultrasound-guided biopsies of the mass were performed. The pathological examination showed a poorly differentiated adenocarcinoma. Immunohistological analysis was strongly suggestive of adenocarcinoma of the seminal vesicle. At surgical exploration, it was impossible to make cystoprostato-vesiculectomy because the tumor was locally advanced. We decided to make hormonal blockage by antiandrogen and five sessions of radiotherapy. Unfortunately, the patient died 5 months later. Adenocarcinoma of the seminal vesicles is a rare diagnosis. We must think in this diagnosis when relatively young patient is presented with dysuria, hematuria or hemospermia and when we found hard palpable mass on digital rectal examination associated to normal PSA level. On histology, specific immunohistochemical markers would be helpful in this differential diagnosis. Actually, surgical excision is the mainstay of the treatment. Radiotherapy and androgen deprivation therapy can be an alternative in locally advanced and metastatic carcinomas. World J Nephrol Urol. 2015;4(3):242-246 doi: http://dx.doi.org/10.14740/wjnu204e
- 1 January 2015
- Published by Elmer Press, Inc. in World Journal of Nephrology and Urology
- Vol. 4 (3) , 242-246
Open AccessPrimary Seminal Vesicle Adenocarcinoma Presenting as Acute Urinary Retention and Hematuria: A Case Report
Primary tumors of the seminal vesicle are extremely rare lesions, and adenocarcinoma is the most common histology found. We report the case of a 54-year-old patient who has consulted with a bladder outlet obstruction and two episodes of initial hematuria for 3 months. Digital rectal examination revealed a hard, palpable mass in the prostate wall. The prostate-specific antigen (PSA), the serum carcinoembryonic antigen and the cancer antigen 125 (CA125) were normal. On imaging, a prostatic abscess, granulomatous prostatitis or a prostatic cancer were highly suspected at first. But the patient was afebrile and PSA was normal. Transrectal ultrasound-guided biopsies of the mass were performed. The pathological examination showed a poorly differentiated adenocarcinoma. Immunohistological analysis was strongly suggestive of adenocarcinoma of the seminal vesicle. At surgical exploration, it was impossible to make cystoprostato-vesiculectomy because the tumor was locally advanced. We decided to make hormonal blockage by antiandrogen and five sessions of radiotherapy. Unfortunately, the patient died 5 months later. Adenocarcinoma of the seminal vesicles is a rare diagnosis. We must think in this diagnosis when relatively young patient is presented with dysuria, hematuria or hemospermia and when we found hard palpable mass on digital rectal examination associated to normal PSA level. On histology, specific immunohistochemical markers would be helpful in this differential diagnosis. Actually, surgical excision is the mainstay of the treatment. Radiotherapy and androgen deprivation therapy can be an alternative in locally advanced and metastatic carcinomas. World J Nephrol Urol. 2015;4(3):242-246 doi: http://dx.doi.org/10.14740/wjnu204e
- Open Access
- 25 December 2013
- Published by Elsevier in Urology Case Reports
- Vol. 2 (1) , 1-3
Growing Teratoma Syndrome After Treatment of a Nonseminomatous Germ Cell Tumor: A Case Report and a Review of Literature
- 25 December 2013
- Published by Elsevier in Urology Case Reports
- Vol. 2 (1) , 1-3
Open AccessGrowing Teratoma Syndrome After Treatment of a Nonseminomatous Germ Cell Tumor: A Case Report and a Review of Literature
- 1 May 2010
- Published by JLE in Annales de biologie clinique
- Vol. 68 (3) , 297-303
Prévalence des infections à papillomavirus (HPV) dans les lésions précancéreuses et cancéreuses du col utérin en Tunisie
To investigate the distribution of HPV genotypes inuterine cervical lesions in Central Tunisia in order to predict the impact ofHPV vaccines and HPV-based screening tests among Tunisian women. We performed a retrospective study of 146 fixed tissues including 30 benign lesions, 36 low-grade cervical intraepithelial neoplasias (CIN1), 45 high-grade cervical intraepithelial neoplasias (CIN2/3), 26 invasive squamous cell carcinomas (SCC) and 9 adenocarcinomas. HPV infection detection and typing were investigated by PCR technique using consensus GP5/GP6 primers and type specific primers for HPV6/11, 16, 18, 31 and 33. Among our patients, overall HPV prevalence was 73.6% (p = 0.0001). HPV infection was associated to 84% of precancerous lesions and 83.9% of cancers. High-risk HPV infection (HPV16 and 18) was detected in 17.4% of CIN1, 74.3% of CIN2/3 (p = 0.002) and 73.1% of cancers (p = 0.001). HPV16 was the most common type among CIN2/3 (51.2%, p < 0.001), invasive SCC (47.6%, p = 0.001) and adenocarcinomas (80%, p < 0.001). This study supports previous population-based studies in which similar HPV detection rates were found among random samples of women. HPV-based screening tests and HPV vaccination would be efficient in uterine cervix cancer prevention among women in the Central Tunisia.
- 1 May 2010
- Published by JLE in Annales de biologie clinique
- Vol. 68 (3) , 297-303
Prévalence des infections à papillomavirus (HPV) dans les lésions précancéreuses et cancéreuses du col utérin en Tunisie
To investigate the distribution of HPV genotypes inuterine cervical lesions in Central Tunisia in order to predict the impact ofHPV vaccines and HPV-based screening tests among Tunisian women. We performed a retrospective study of 146 fixed tissues including 30 benign lesions, 36 low-grade cervical intraepithelial neoplasias (CIN1), 45 high-grade cervical intraepithelial neoplasias (CIN2/3), 26 invasive squamous cell carcinomas (SCC) and 9 adenocarcinomas. HPV infection detection and typing were investigated by PCR technique using consensus GP5/GP6 primers and type specific primers for HPV6/11, 16, 18, 31 and 33. Among our patients, overall HPV prevalence was 73.6% (p = 0.0001). HPV infection was associated to 84% of precancerous lesions and 83.9% of cancers. High-risk HPV infection (HPV16 and 18) was detected in 17.4% of CIN1, 74.3% of CIN2/3 (p = 0.002) and 73.1% of cancers (p = 0.001). HPV16 was the most common type among CIN2/3 (51.2%, p < 0.001), invasive SCC (47.6%, p = 0.001) and adenocarcinomas (80%, p < 0.001). This study supports previous population-based studies in which similar HPV detection rates were found among random samples of women. HPV-based screening tests and HPV vaccination would be efficient in uterine cervix cancer prevention among women in the Central Tunisia.